Drug Shortage Report for PROCAINAMIDE HYDROCHLORIDE INJECTION USP
Report ID | 2559 |
Drug Identification Number | 02184486 |
Brand name | PROCAINAMIDE HYDROCHLORIDE INJ. USP |
Common or Proper name | PROCAINAMIDE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | PROCAINAMIDE |
Strength(s) | 100mg/mL |
Dosage form(s) | INJ |
Route of administration | Intra |
Packaging size | 10x10mLV |
ATC code | C01BA |
ATC description | ANTIARRHYTHMICS, CLASS I AND III |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2017-03-14 |
Actual start date | |
Estimated end date | 2017-08-18 |
Actual end date | 2017-08-18 |
Shortage status | Resolved |
Updated date | 2017-10-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2017-10-25 | French | Compare |
v8 | 2017-10-25 | English | Compare |
v7 | 2017-08-07 | French | Compare |
v6 | 2017-08-07 | English | Compare |
v5 | 2017-03-21 | French | Compare |
v4 | 2017-03-21 | English | Compare |
v3 | 2017-03-15 | English | Compare |
v2 | 2017-03-14 | French | Compare |
v1 | 2017-03-14 | English | Compare |
Showing 1 to 9 of 9